REFERENCES
- Kipper M. S., Taylor A., Jr. Nuclear Medicine in the Evaluation of Endocrine Disease. Clinical Practice of Nuclear Medicine, A. Taylor, Jr., F. L. Datz. Churchill Livingstone Inc., New York 1991; 153–181
- Kao C. H., Lin W. Y., Wang S. J., Yeh S. H. Visualization of Suppressed Thyroid Tissue by Tc-99m MIBI. Clin. Nucl. Med. 1991; 16: 812–814
- Alonso O., Mut F., Lago G., Aznarez A., Nunez M., Canepa J., Touya E. Tc-99m-MIBI Scanning of the Thyroid Gland in Patients with Markedly Decreased Pertechnetate Uptake. Nucl. Med. Commun. 1998; 19: 257–261
- Higley B., Smith F. W., Smith T. Technetium-99m-1,2-bis(bis(2-Ethoxyethyl)Phosphino) Ethane: Human Biodistribution, Dosimetry and Safety of a New Myocardial Perfusion Imaging Agent. J. Nucl. Med. 1993; 34: 30–38, et al.
- Kelly J. D., Forster A. M., Higley B. Technetium-99m-Tetrofosmin as a New Radiopharmaceutical for Myocardial Perfusion Imaging. J. Nucl. Med. 1993; 34: 222–227
- Gallowitsch H. J., Kresnik E., Mikosch P., Pipam W., Gomez I., Lind P. Tc-99m-Tetrofosmin Scintigraphy: an Alternative Scintigraphic Method for Following up Differentiated Thyroid Carcinoma—Preliminary Results. Nuklearmedizin 1996; 35: 230–235
- Kanmaz B., Erdil T. Y., Yardi O. F. The Role of 99Tcm-Tetrofosmin in the Evaluation of Thyroid Nodules. Nucl. Med. Commun. 2000; 21: 333–339, et al.
- Klain M., Maurea S., Cuocolo A., Colao A., Marzano L., Lombardi G., Salvatore M. Technetium-99m Tetrofosmin Imaging in Thyroid Diseases: Comparison with Tc-99m-Pertechnetate, Thallium-201 and Tc-99m-Methoxyisobutylisonitrile Scans. Eur. J. Nucl. Med. 1996; 23: 1568–1574
- Kosuda S., Yokoyama H., Katayama M., Yokokawa T., Kusano S., Yamamoto O. Technetium-99m Tetrofosmin and Technetium-99m Sestamibi Imaging of Multiple Metastases from Differentiated Thyroid Carcinoma. Eur. J. Nucl. Med. 1995; 22: 1218–1220
- Nemec J., Nyvltova O., Preiningerova M., Vlcek P., Racek P., Novak Z., Blazek T., Zimak J. Positive Thyroid Cancer Scintigraphy Using Tc-99m Tetrofosmin (Myoview): a Preliminary Report. Nucl. Med. Commun. 1995; 16: 694–697
- Hiromatsu Y., Ishibashi M., Miyake I., Nonaka K. Technetium-99m Tetrofosmin Imaging in Patients with Subacute Thyroiditis. Eur. J. Nucl. Med. 1998; 25: 1448–1452
- Kao C. H., Shen Y. Y., Lee J. K., Wang S. J. Discrepancy Between 24-Hour I-131 and 30-Minute Tc-99m Tetrofosmin Thyroid Imaging in Thyroiditis. Clin. Nucl. Med. 1997; 22: 564–565
- Ross D. S. Syndromes of Thyrotoxicosis with Low Radioactive Iodine Uptake. Endocrinol. Metab. Clinics. North. Am. 1998; 27: 169–185
- Chiu M. L., Kronauge J. F., Piwnica-Worms D. Effect of Mitochondrial and Plasma Membrane Potentials on Accumulation of Hexakis (2-Methoxyiso-butylisonitrile) Technetium (I) in Cultured Mouse Fibroblast. J. Nucl. Med. 1990; 31: 1646–1653
- Piwnica-Worms D., Holman B. L. Noncardiac Application of Hexakis (Alkyl-isonitrile) Technetium-99m Complexes [Editorial]. J. Nucl. Med. 1990; 31: 1166–1167
- Platts E. A., North T. L., Pickett R. D., Kelly J. D. Mechanism of Uptake of Technetium-Tetrofosmin. I: Uptake Into Isolated Adult Rat Ventricular Myocytes and Subcellular Localization. J. Nucl. Cardiol. 1995; 2: 317–326
- Younes A., Songadele J. A., Maublant J., Platts E., Pickett R., Veyre A. Mechanism of Uptake of Technetium-Tetrofosmin. II: Uptake into Isolated Adult Rat Heart Mitochondria. J. Nucl. Cardiol. 1995; 2: 327–333
- Johannessen J. V. Electron Microscopy in Human Medicine, Vol. 10. Endocrine Organs, Part II: the Thyroid Gland. McGraw-Hill, New York 1981; 29–107
- Weihl A. C., Daniels G. H., Ridgway E. C., Maloof F. Thyroid Function Tests During the Early Phase of Subacute Thyroiditis. J. Clin. Endocrinol. Metab. 1977; 44: 1107–1114